跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,716 条关于
“IL-36α”
全部
3,716
临床试验
1,563
药物
774
机构
22
资讯
1,357
去年
Spesolimab Shows Promise in Treating Pediatric Generalized Pustular Psoriasis
2年前
Turn Therapeutics' GX-03 Shows Promise in Atopic Dermatitis by Inhibiting Key Cytokines
12个月前
Landmark Clinical Trials Demonstrate Efficacy of IL-13 and IL-4/IL-13 Inhibitors in Patients with Darker Skin Tones
去年
Medicenna Secures Five New Patents for IL-2 and IL-4 Superkine Immunotherapies
8个月前
Turn Therapeutics Advances Phase 2 Atopic Dermatitis Trial with First-in-Class IL-36/IL-31 Inhibitor GX-03
2年前
Medicenna Presents Preclinical Data on IL-2 Super-Antagonist MDNA209 and Anti-PD1-IL-2 BiSKIT MDNA113
去年
IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients
10个月前
Mabwell's Anti-IL-11 Antibody 9MW3811 Becomes World's First IL-11 Therapeutic to Enter Phase II for Pathological Scarring
昨天
Aethlon and North Immunology Merge to Advance IL-13 x IL-18 Bispecific Antibody NOR-101 for Atopic Dermatitis
上个月
Infinimmune Raises $75M Series A to Advance IL-22 and IL-13 Antibodies for Atopic Dermatitis Toward 2027 Clinical Entry
第 1 页,共 136 页
上一页
下一页